上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1424Please respect copyright.PENANANQspcmaohT
1424Please respect copyright.PENANAmozaxgRwwU
上集:https://www.penana.com/article/4711251424Please respect copyright.PENANAqO3dOEX4bm
1424Please respect copyright.PENANAZPOeenSzT71424Please respect copyright.PENANAfNw6kC0Eic
1424Please respect copyright.PENANA5c0iOQhYX4
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1424Please respect copyright.PENANAb41kCcRWBy
1424Please respect copyright.PENANA7ssPS23yrm
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1424Please respect copyright.PENANAKY7LHA7lSP
1424Please respect copyright.PENANAdpJl4uGqmJ
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1424Please respect copyright.PENANAcF8B1JMFbB
1424Please respect copyright.PENANA2L2nOr5ctf1424Please respect copyright.PENANA551KgbVqaZ
1424Please respect copyright.PENANACGAfWOdpsG
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1424Please respect copyright.PENANAJOq8XFd169
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1424Please respect copyright.PENANAKzlZ15Sbic
1424Please respect copyright.PENANA8zJgUNmwUx
忘記甚麼是Neoantigen的話,可重溫上一集。1424Please respect copyright.PENANAWCbaXfKtx7
1424Please respect copyright.PENANACUiqUqZmDc
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1424Please respect copyright.PENANAWLVmAzoGXC
1424Please respect copyright.PENANAoQGetE0bIT
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1424Please respect copyright.PENANAXF6x0WJInN
1424Please respect copyright.PENANApSFmAeBADJ1424Please respect copyright.PENANA8c21c0OS7K
1424Please respect copyright.PENANA3yOdyb9CF8
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1424Please respect copyright.PENANAHHc73iRLOw
1424Please respect copyright.PENANAyIDIcSxCDH
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1424Please respect copyright.PENANAzlLicvX3xt
1424Please respect copyright.PENANAg9EzUEXnpb
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1424Please respect copyright.PENANAfgTJeD1cEe1424Please respect copyright.PENANAxLHLsp0N0G
1424Please respect copyright.PENANAh2EQegaPLQ
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1424Please respect copyright.PENANAfjwd6sDE9M
1424Please respect copyright.PENANAysD8xQWjdi
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1424Please respect copyright.PENANAot40Bpuymr1424Please respect copyright.PENANAXWlxusbIiR
1424Please respect copyright.PENANAISNgI6huPn
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1424Please respect copyright.PENANAAmuGcaeZc7
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1424Please respect copyright.PENANAgoOYExE5xF
1424Please respect copyright.PENANAgNJEOD3FOb
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1424Please respect copyright.PENANAJNAaVKB7Fh
1424Please respect copyright.PENANAvlT7cxUZQS
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1424Please respect copyright.PENANAYPnrWnBk01
1424Please respect copyright.PENANAEZl8GNrheZ
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1424Please respect copyright.PENANAoNFVNQnrHG
1424Please respect copyright.PENANAVPuVoaQWvy
1424Please respect copyright.PENANA7PNFGwpBUJ
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1424Please respect copyright.PENANAXBAzbFQWv2
1424Please respect copyright.PENANAZdYeoI2r4L
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1424Please respect copyright.PENANAZ3lPbGuHv4
1424Please respect copyright.PENANAMYdzS4TiVV
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1424Please respect copyright.PENANAZf1PY7jrd4
1424Please respect copyright.PENANANYF9lk9n57
Link:1424Please respect copyright.PENANAYAW7myF6zy
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1424Please respect copyright.PENANAXEUH3b6Orf
1424Please respect copyright.PENANAWb83V6k9W3
1424Please respect copyright.PENANAnHK3zx8jaU
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1424Please respect copyright.PENANAFYv0OFPh0o